A Magnetic Resonance Spectroscopy (MRS) study to explore the effects of a medical food on brain metabolites in patients with mild Alzheimer's Disease dementia(AD) - MRS AD study

utricia Research0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•-Diagnosis of significant neurological and/or psychiatric disease other than AD
•-Use within 3 months prior to baseline, or expected need during the study of donepezil, rivastigmine, galantamine, and/or memantine
•-Geriatric Depression Scale > 6 on 15-item scale
•-Hachinski Ischemia Scale score > 5
•-Use within two months prior to baseline of: omega-3 fatty acid containing supplements, oily fish (when consumed more than twice a week)
•-Use within one month prior to baseline of: atropine, scopolamine, tolterodine, hyoscyamine, biperiden, benztropine, trihexyphenidyl, oxybutynin, antipsychotics, vitamins B, C and/ or E > 200% RDI, high energy and/ or high protein nutritional supplements/medical foods, other investigational products
•-Investigator*s uncertainty about willingness, ability, or medical status of patient to comply with protocol requirements

发起方

utricia Research